BMJ Best Practice

参考文献

关键文献

Barlow SE. Expert Committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary report. Pediatrics. 2007 Dec;120(suppl 4):S164-92.

Speiser PW, Rudolf MC, Anhalt H, et al. Childhood obesity. J Clin Endocrinol Metab. 2005 Mar;90(3):1871-87.

Spear BA, Barlow SE, Ervin C, et al. Recommendations for treatment of child and adolescent overweight and obesity. Pediatrics. 2007 Dec;120(suppl 4):S254-88.

US Department of Health and Human Services and US Department of Agriculture. 2015-2020 dietary guidelines for Americans, 8th edition. December 2015 [internet publication].

Wald AB, Uli NK. Pharmacotherapy in pediatric obesity: current agents and future directions. Rev Endocr Metab Disord. 2009 Sep;10(3):205-14.

Park MH, Kinra S, Ward KJ, et al. Metformin for obesity in children and adolescents: a systematic review. Diabetes Care. 2009 Sep;32(9):1743-5.

Wasserman H, Inge TH. Bariatric surgery in obese adolescents: opportunities and challenges. Pediatr Ann. 2014 Sep;43(9):e230-6.

参考文章

1.  Mei Z, Grummer-Strawn LM, Pietrobelli A, et al. Validity of body mass index compared with other body-composition screening indexes for the assessment of body fatness in children and adolescents. Am J Clin Nutr. 2002 Jun;75(6):978-85.

2.  Ogden CL, Kuczmarski RJ, Flegal KM, et al. Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version. Pediatrics. 2002 Jan;109(1):45-60.

3.  Barlow SE. Expert Committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary report. Pediatrics. 2007 Dec;120(suppl 4):S164-92.

4.  Canoy D, Bundred P. Obesity in children. BMJ Clin Evid. 2011 Apr 4;2011. pii: 0325.

5.  Health and Social Care Information Centre. Statistics on obesity, physical activity and diet: England, January 2008 [internet publication].

6.  Ogden CL, Carroll MD, Curtin LR, et al. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA. 2006 Apr 5;295(13):1549-55.

7.  Skinner AC, Ravanbakht SN, Skelton JA, et al. Prevalence of obesity and severe obesity in US children, 1999-2016. Pediatrics. 2018 Mar;141(3). pii: e20173459.

8.  Whitaker RC, Wright JA, Pepe MS, et al. Predicting obesity in young adulthood from childhood and parental obesity. N Engl J Med. 1997 Sep 25;337(13):869-73.

9.  Ogden CL, Carroll MD, Fryar CD, et al. Prevalence of obesity among adults and youth: United States, 2011-2014. NCHS Data Brief. 2015 Nov;(219):1-8.

10.  Nader PR, O'Brien M, Houts R, et al. Identifying risk for obesity in early childhood. Pediatrics. 2006 Sep;118(3):e594-601.

11.  Speiser PW, Rudolf MC, Anhalt H, et al. Childhood obesity. J Clin Endocrinol Metab. 2005 Mar;90(3):1871-87.

12.  Gordon-Larsen P, Adair LS, Popkin BM. Ethnic differences in physical activity and inactivity patterns and overweight status. Obes Res. 2002 Mar;10(3):141-9.

13.  Malik VS, Schulze MB, Hu FB. Intake of sugar-sweetened beverages and weight gain: a systematic review. Am J Clin Nutr. 2006 Aug;84(2):274-88.

14.  Kann L, McManus T, Harris WA, et al.; Centers for Disease Control and Prevention. Youth risk behavior surveillance - United States, 2015. MMWR Surveill Summ. 2016 Jun 10;65(6):1-174.

15.  Epstein LH, Roemmich JN, Robinson JL, et al. A randomized trial of the effects of reducing television viewing and computer use on body mass index in young children. Arch Pediatr Adolesc Med. 2008 Mar;162(3):239-45.

16.  Ong KK, Loos RJ. Rapid infancy weight gain and subsequent obesity: systematic reviews and hopeful suggestions. Acta Paediatr. 2006 Aug;95(8):904-8.

17.  Chomtho S, Wells JC, Williams JE, et al. Infant growth and later body composition: evidence from the 4-component model. Am J Clin Nutr. 2008 Jun;87(6):1776-84.

18.  Geserick M, Vogel M, Gausche R, et al. Acceleration of BMI in early childhood and risk of sustained obesity. N Engl J Med. 2018 Oct 4;379(14):1303-12.

19.  Freedman DS, Khan LK, Dietz WH, et al. Relationship of childhood obesity to coronary heart disease risk factors in adulthood: the Bogalusa Heart Study. Pediatrics. 2001 Sep;108(3):712-8.

20.  Must A, Strauss RS. Risks and consequences of childhood and adolescent obesity. Int J Obes Relat Metab Disord. 1999 Mar;23(suppl 2):S2-11.

21.  Taveras EM, Rifas-Shiman SL, Oken E, et al. Short sleep duration in infancy and risk of childhood overweight. Arch Pediatr Adolesc Med. 2008 Apr;162(4):305-11.

22.  Liu X, Forbes EE, Ryan ND, et al. Rapid eye movement sleep in relation to overweight in children and adolescents. Arch Gen Psychiatry. 2008 Aug;65(8):924-32.

23.  Halal CS, Matijasevich A, Howe LD, et al. Short sleep duration in the first years of life and obesity/overweight at age 4 years: a birth cohort study. J Pediatr. 2016 Jan;168:99-103.e3.

24.  Dubois L, Girard M. Early determinants of overweight at 4.5 years in a population-based longitudinal study. Int J Obes (Lond). 2006 Apr;30(4):610-7.

25.  Vohr BR, Boney CM. Gestational diabetes: the forerunner for the development of maternal and childhood obesity and metabolic syndrome? J Matern Fetal Neonatal Med. 2008 Mar;21(3):149-57.

26.  Morton GJ, Cummings DE, Baskin DG, et al. Central nervous system control of food intake and body weight. Nature. 2006 Sep 21;443(7109):289-95.

27.  Moore LL, Gao D, Bradlee ML, et al. Does early physical activity predict body fat change throughout childhood? Prev Med. 2003 Jul;37(1):10-7.

28.  Ludwig DS, Peterson KE, Gortmaker SL. Relation between consumption of sugar-sweetened drinks and childhood obesity: a prospective, observational analysis. Lancet. 2001 Feb 17;357(9255):505-8.

29.  Golden NH, Schneider M, Wood C, et al. Preventing obesity and eating disorders in adolescents. Pediatrics. 2016 Sep;138(3). pii: e20161649.

30.  Griffiths LJ, Smeeth L, Hawkins SS, et al. Effects of infant feeding practice on weight gain from birth to 3 years. Arch Dis Child. 2009 Aug;94(8):577-82.

31.  Kramer MS, Matush L, Vanilovich I, et al. A randomized breast-feeding promotion intervention did not reduce child obesity in Belarus. J Nutr. 2009 Feb;139(2):417-21S.

32.  Heyman MB, Abrams SA; Committee on Nutrition. Fruit juice in infants, children, and adolescents: current recommendations. Pediatrics. 2017 Jun;139(6). pii: e20170967.

33.  Bleich SN, Vercammen KA, Zatz LY, et al. Interventions to prevent global childhood overweight and obesity: a systematic review. Lancet Diabetes Endocrinol. 2018 Apr;6(4):332-46.

34.  Wyatt K, Lloyd J, Creanor S, et al. Cluster randomised controlled trial and economic and process evaluation to determine the effectiveness and cost-effectiveness of a novel intervention [Healthy Lifestyles Programme (HeLP)] to prevent obesity in school children. Southampton (UK): NIHR Journals Library; 2018 Jan.

35.  Dhana K, Haines J, Liu G, et al. Association between maternal adherence to healthy lifestyle practices and risk of obesity in offspring: results from two prospective cohort studies of mother-child pairs in the United States. BMJ. 2018 Jul 4;362:k2486.

36.  Waters E, de Silva-Sanigorski A, Hall BJ, et al. Interventions for preventing obesity in children. Cochrane Database Syst Rev. 2011;(12):CD001871.

37.  Ogden CL, Carroll MD, Flegal KM. High body mass index for age among US children and adolescents, 2003-2006. JAMA. 2008 May 28;299(20):2401-5.

38.  Marcovecchio ML, Patricelli L, Zito M, et al. Ambulatory blood pressure monitoring in obese children: role of insulin resistance. J Hypertens. 2006 Dec;24(12):2431-6.

39.  Freedman DS, Khan LK, Serdula MK, et al. Inter-relationships among childhood BMI, childhood height, and adult obesity: the Bogalusa Heart Study. Int J Obes Relat Metab Disord. 2004 Jan;28(1):10-6.

40.  Taksali SE, Caprio S, Dziura J, et al. High visceral and low abdominal subcutaneous fat stores in the obese adolescent: a determinant of an adverse metabolic phenotype. Diabetes. 2008 Feb;57(2):367-71.

41.  Maffeis C, Pietrobelli A, Grezzani A, et al. Waist circumference and cardiovascular risk factors in prepubertal children. Obes Res. 2001 Mar;9(3):179-87.

42.  Alberti KG, Zimmet P, Shaw J. Metabolic syndrome: a new world-wide definition. Diabet Med. 2006 May;23(5):469-80.

43.  Sardinha LB, Going SB, Teixeira PJ, et al. Receiver operating characteristic analysis of body mass index, triceps skinfold thickness, and arm girth for obesity screening in children and adolescents. Am J Clin Nutr. 1999 Dec;70(6):1090-5.

44.  Thompson DL, Thompson WR, Prestridge TJ, et al. Effects of hydration and dehydration on body composition analysis: a comparative study of bioelectric impedance analysis and hydrodensitometry. J Sports Med Phys Fitness. 1991 Dec;31(4):565-70.

45.  Stanforth PR, Jackson AS, Green JS, et al. Generalized abdominal visceral fat prediction models for black and white adults aged 17-65 y: the HERITAGE Family Study. Int J Obes Relat Metab Disord. 2004 Jul;28(7):925-32.

46.  American Diabetes Association. 2. Classification and Diagnosis of Diabetes. Diabetes Care. 2018 Jan;41(suppl 1):S13-S27.

47.  US Department of Health and Human Services: National Heart, Lung, and Blood Institute. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: full report. October 2012 [internet publication].

48.  Barness LA, Opitz JM, Gilbert-Barness E. Obesity: genetic, molecular, and environmental aspects. Am J Med Genet A. 2007 Dec 15;143A(24):3016-34.

49.  Farooqi S, O'Rahilly S. Genetics of obesity in humans. Endocr Rev. 2006 Dec;27(7):710-18.

50.  Farooqi IS. Monogenic human obesity. Front Horm Res. 2008;36:1-11.

51.  Vaisse C, Clement K, Durand E, et al. Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity. J Clin Invest. 2000 Jul;106(2):253-62.

52.  US Preventive Services Task Force. Screening for obesity in children and adolescents: US Preventive Services Task Force recommendation statement. JAMA. 2017 Jun 20;317(23):2417-26.

53.  Spear BA, Barlow SE, Ervin C, et al. Recommendations for treatment of child and adolescent overweight and obesity. Pediatrics. 2007 Dec;120(suppl 4):S254-88.

54.  Uli N, Sundararajan S, Cuttler L. Treatment of childhood obesity. Curr Opin Endocrinol Diabetes Obes. 2008 Feb;15(1):37-47.

55.  Ho M, Garnett SP, Baur L, et al. Effectiveness of lifestyle interventions in child obesity: systematic review with meta-analysis. Pediatrics. 2012 Dec;130(6):e1647-71.

56.  O'Connor EA, Evans CV, Burda BU, et al. Screening for obesity and intervention for weight management in children and adolescents: evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2017 Jun 20;317(23):2427-44.

57.  Michalsky MP, Inge TH, Jenkins TM, et al. Cardiovascular risk factors after adolescent bariatric surgery. Pediatrics. 2018 Feb;141(2). pii: e20172485.

58.  Mackey ER, Wang J, Harrington C, et al. Psychiatric diagnoses and weight loss among adolescents receiving sleeve gastrectomy. Pediatrics. 2018 Jul;142(1). pii: e20173432.

59.  Golan M. Parents as agents of change in childhood obesity - from research to practice. Int J Pediatr Obes. 2006;1(2):66-76.

60.  James J, Thomas P, Cavan D, et al. Preventing childhood obesity by reducing consumption of carbonated drinks: cluster randomised controlled trial. BMJ. 2004 May 22;328(7450):1237.

61.  Chen L, Appel LJ, Loria C, et al. Reduction in consumption of sugar-sweetened beverages is associated with weight loss: the PREMIER trial. Am J Clin Nutr. 2009 May;89(5):1299-306.

62.  Gibson LJ, Peto J, Warren JM, et al. Lack of evidence on diets for obesity for children: a systematic review. Int J Epidemiol. 2006 Dec;35(6):1544-52.

63.  Strong WB, Malina RM, Blimkie CJ, et al. Evidence based physical activity for school-age youth. J Pediatr. 2005 Jun;146(6):732-7.

64.  US Department of Health and Human Services and US Department of Agriculture. 2015-2020 dietary guidelines for Americans, 8th edition. December 2015 [internet publication].

65.  Adachi-Mejia AM, Longacre MR, Gibson JJ, et al. Children with a TV in their bedroom at higher risk for being overweight. Int J Obes (Lond). 2007 Apr;31(4):644-51.

66.  Robinson TN. Television viewing and childhood obesity. Pediatr Clin North Am. 2001 Aug;48(4):1017-25.

67.  Barnett TA, Kelly AS, Young DR, et al. Sedentary behaviors in today's youth: approaches to the prevention and management of childhood obesity: a scientific statement from the American Heart Association. Circulation. 2018 Sep 11;138(11):e142-59.

68.  Wilfley DE, Stein RI, Saelens BE, et al. Efficacy of maintenance treatment approaches for childhood overweight: a randomized controlled trial. JAMA. 2007 Oct 10;298(14):1661-73.

69.  Epstein LH, Valoski A, Wing RR, et al. Ten-year outcomes of behavioral family-based treatment for childhood obesity. Health Psychol. 1994 Sep;13(5):373-83.

70.  Boutelle KN, Rhee KE, Liang J, et al. Effect of attendance of the child on body weight, energy intake, and physical activity in childhood obesity treatment: a randomized clinical trial. JAMA Pediatr. 2017;171(7):622–28.

71.  Mead E, Atkinson G, Richter B, et al. Drug interventions for the treatment of obesity in children and adolescents. Cochrane Database Syst Rev. 2016;(11):CD012436.

72.  Dunican KC, Desilets AR, Montalbano JK. Pharmacotherapeutic options for overweight adolescents. Ann Pharmacother. 2007 Sep;41(9):1445-55.

73.  Wald AB, Uli NK. Pharmacotherapy in pediatric obesity: current agents and future directions. Rev Endocr Metab Disord. 2009 Sep;10(3):205-14.

74.  Boland CL, Harris JB, Harris KB. Pharmacological management of obesity in pediatric patients. Ann Pharmacother. 2015 Feb;49(2):220-32.

75.  Chanoine JP, Hampl S, Jensen C, et al. Effect of orlistat on weight and body composition in obese adolescents: a randomized controlled trial. JAMA. 2005 Jun 15;293(23):2873-83.

76.  European Medicines Agency. Press release: European Medicines Agency recommends suspension of marketing authorisations for sibutramine. January 2010 [internet publication].

77.  Freemark M, Bursey D. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes. Pediatrics. 2001 Apr;107(4):e55.

78.  Kay JP, Alemzadeh R, Langley G, et al. Beneficial effects of metformin in normoglycemic morbidly obese adolescents. Metabolism. 2001 Dec;50(12):1457-61.

79.  Desilets AR, Dhakal-Karki S, Dunican KC. Role of metformin for weight management in patients without type 2 diabetes. Ann Pharmacother. 2008 Jun;42(6):817-26.

80.  Park MH, Kinra S, Ward KJ, et al. Metformin for obesity in children and adolescents: a systematic review. Diabetes Care. 2009 Sep;32(9):1743-5.

81.  Bouza C, López-Cuadrado T, Gutierrez-Torres LF, et al. Efficacy and safety of metformin for treatment of overweight and obesity in adolescents: an updated systematic review and meta-analysis. Obes Facts. 2012;5(5):753-65.

82.  McDonagh MS, Selph S, Ozpinar A, et al. Systematic review of the benefits and risks of metformin in treating obesity in children aged 18 years and younger. JAMA Pediatr. 2014 Feb;168(2):178-84.

83.  Pastor-Villaescusa B, Cañete MD, Caballero-Villarraso J, et al. Metformin for obesity in prepubertal and pubertal children: a randomized controlled trial. Pediatrics. Pediatrics. 2017 Jul;140(1). pii: e20164285.

84.  Keidar A, Hecht L, Weiss R. Bariatric surgery in obese adolescents. Curr Opin Clin Nutr Metab Care. 2011 May;14(3):286-90.

85.  Aikenhead A, Knai C, Lobstein T. Effectiveness and cost-effectiveness of paediatric bariatric surgery: a systematic review Clin Obes. 2011 Feb;1(1):12-25.

86.  White B, Doyle J, Colville S, et al. Systematic review of psychological and social outcomes of adolescents undergoing bariatric surgery, and predictors of success. Clin Obes. 2015 Dec;5(6):312-24.

87.  Ells LJ, Mead E, Atkinson G, et al. Surgery for the treatment of obesity in children and adolescents. Cochrane Database Syst Rev. 2015;(6):CD011740.

88.  Inge TH, Courcoulas AP, Jenkins TM, et al; Teen-LABS Consortium. Weight loss and health status 3 years after bariatric surgery in adolescents. N Engl J Med. 2016 Jan 14;374(2):113-23.

89.  Wasserman H, Inge TH. Bariatric surgery in obese adolescents: opportunities and challenges. Pediatr Ann. 2014 Sep;43(9):e230-6.

90.  Fullmer MA, Abrams SH, Hrovat K, et al. Nutritional strategy for adolescents undergoing bariatric surgery: report of a working group of the Nutrition Committee of NASPGHAN/NACHRI. J Pediatr Gastroenterol Nutr. 2012 Jan;54(1):125-35.

91.  Kopelman P, Groot Gde H, Rissanen A, et al. Weight loss, HbA1c reduction, and tolerability of cetilistat in a randomized, placebo-controlled phase 2 trial in obese diabetics: comparison with orlistat (Xenical). Obesity. 2010 Jan;18(1):108-15.

92.  Bray GA. Medical therapy for obesity - current status and future hopes. Med Clin North Am. 2007 Nov;91(6):1225-53, xi.

93.  Smith SR, Aronne LJ, Burns CM, et al. Sustained weight loss following 12-month pramlintide treatment as an adjunct to lifestyle intervention in obesity. Diabetes Care. 2008 Sep;31(9):1816-23.

94.  Pi-Sunyer FX, Aronne LJ, Heshmati HM, et al; RIO-North America Study Group. Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients. RIO-North America: a randomized controlled trial. JAMA. 2006 Feb 15;295(7):761-75.

95.  Christensen R, Kristensen PK, Bartels EM, et al. Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials. Lancet. 2007 Nov 17;370(9600):1706-13.

96.  Greenway FL, Fujioka K, Plodkowski RA, et al. Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2010 Aug 21;376(9741):595-605.

97.  Klonoff DC, Buse JB, Nielsen LL, et al. Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years. Curr Med Res Opin. 2008 Jan;24(1):275-86.

98.  Kelly AS, Rudser KD, Nathan BM, et al. The effect of glucagon-like peptide-1 receptor agonist therapy on body mass index in adolescents with severe obesity: a randomized, placebo-controlled, clinical trial. JAMA Pediatr. 2013 Apr;167(4):355-60.

99.  Kelly AS, Metzig AM, Rudser KD, et al. Exenatide as a weight-loss therapy in extreme pediatric obesity: a randomized, controlled pilot study. Obesity (Silver Spring). 2012 Feb;20(2):364-70.

100.  Fenske WK, Bueter M, Miras AD, et al. Exogenous peptide YY3-36 and Exendin-4 further decrease food intake, whereas octreotide increases food intake in rats after Roux-en-Y gastric bypass. Int J Obes (Lond). 2012 Mar;36(3):379-84.

101.  Smith SR, Prosser WA, Donahue DJ, et al. Lorcaserin (APD356), a selective 5-HT(2C) agonist, reduces body weight in obese men and women. Obesity. 2009 Mar;17(3):494-503.

102.  Fidler MC, Sanchez M, Raether B, et al. A one-year randomized trial of lorcaserin for weight loss in obese and overweight adults: the BLOSSOM trial. J Clin Endocrinol Metab. 2011 Oct;96(10):3067-77.

103.  Wadden TA, Hollander P, Klein S, et al. Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: the SCALE Maintenance randomized study. Int J Obes (Lond). 2013 Nov;37(11):1443-51.

104.  Guo SS, Wu W, Chumlea WC, et al. Predicting overweight and obesity in adulthood from body mass index values in childhood and adolescence. Am J Clin Nutr. 2002;76:653-658.

105.  Bjerregaard LG, Jensen BW, Ängquist L, et al. Change in overweight from childhood to early adulthood and risk of type 2 diabetes. N Engl J Med. 2018 Apr 5;378(14):1302-12.

106.  Weiss R, Dziura J, Burgert TS, et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med. 2004 Jun 3;350(23):2362-74.

107.  Sinha R, Fisch G, Teague B, et al. Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med. 2002 Mar 14;346(11):802-10.

108.  Giannini C, de Giorgis T, Scarinci A, et al. Obese related effects of inflammatory markers and insulin resistance on increased carotid intima media thickness in pre-pubertal children. Atherosclerosis. 2008 Mar;197(1):448-56.

109.  Freedman DS, Dietz WH, Tang R, et al. The relation of obesity throughout life to carotid intima-media thickness in adulthood: the Bogalusa Heart Study. Int J Obes Relat Metab Disord. 2004 Jan;28(1):159-66.

110.  Gjærde LK, Gamborg M, Ängquist L, et al. Association of childhood body mass index and change in body mass index with first adult ischemic stroke. JAMA Neurol. 2017 Nov 1;74(11):1312-18.

111.  Nguyen TT, Keil MF, Russell DL, et al. Relation of acanthosis nigricans to hyperinsulinemia and insulin sensitivity in overweight African American and white children. J Pediatr. 2001 Apr;138(4):474-80.

112.  Wing YK, Hui SH, Pak WM, et al. A controlled study of sleep related disordered breathing in obese children. Arch Dis Child. 2003 Dec;88(12):1043-7.

113.  Marcus CL, Brooks LJ, Draper KA, et al; American Academy of Pediatrics. Diagnosis and management of childhood obstructive sleep apnea syndrome. Pediatrics. 2012 Sep;130(3):576-84.

114.  Dunn W, Schwimmer JB. The obesity epidemic and nonalcoholic fatty liver disease in children. Curr Gastroenterol Rep. 2008 Feb;10(1):67-72.

115.  Roberts EA. Pediatric nonalcoholic fatty liver disease (NAFLD): a "growing" problem? J Hepatol. 2007 Jun;46(6):1133-42.

116.  Schwimmer JB, Burwinkle TM, Varni JW. Health-related quality of life of severely obese children and adolescents. JAMA. 2003 Apr 9;289(14):1813-9.

117.  Zametkin AJ, Zoon CK, Klein HW, et al. Psychiatric aspects of child and adolescent obesity: a review of the past 10 years. J Am Acad Child Adolesc Psych. 2004 Feb;43(2):134-50.

118.  Needham BL, Crosnoe R. Overweight status and depressive symptoms during adolescence. J Adolesc Health. 2005 Jan;36(1):48-55.

119.  Anderson SE, Cohen P, Naumova EN, et al. Adolescent obesity and risk for subsequent major depressive disorder and anxiety disorder: prospective evidence. Psychosom Med. 2007 Nov;69(8):740-7.

120.  Janicke DM, Harman JS, Kelleher KJ, et al. Psychiatric diagnosis in children and adolescents with obesity-related health conditions. J Dev Behav Pediatr. 2008 Aug;29(4):276-84.

121.  Kaechele V, Wabitsch M, Thiere D, et al. Prevalence of gallbladder stone disease in obese children and adolescents: influence of the degree of obesity, sex, and pubertal development. J Pediatr Gastroenterol Nutr. 2006 Jan;42(1):66-70.

122.  Fishman L, Lenders C, Fortunato C, et al. Increased prevalence of constipation and fecal soiling in a population of obese children. J Pediatr. 2004 Aug;145(2):253-4.

123.  Hampel H, Abraham NS, El-Serag HB. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med. 2005 Aug 2;143(3):199-211.

124.  Wills M. Orthopedic complications of childhood obesity. Pediatr Phys Ther. 2004 Winter;16(4):230-5.

125.  Scott IU, Siatkowski RM, Eneyni M, et al. Idiopathic intracranial hypertension in children and adolescents. Am J Ophthalmol. 1997 Aug;124(2):253-5.

126.  Ford ES. The epidemiology of obesity and asthma. J Allergy Clin Immunol. 2005 May;115(5):897-909.

127.  Corbo GM, Forastiere F, Sario MD, et al. Wheeze and asthma in children: associations with body mass index, sports, television viewing, and diet. Epidemiology. 2008 Sep;19(5):747-55.

128.  Husemoen LL, Glumer C, Lau C, et al. Association of obesity and insulin resistance with asthma and aeroallergen sensitization. Allergy. 2008 May;63(5):575-82.

129.  Khan LK, Sobush K, Keener D, et al. Recommended community strategies and measurements to prevent obesity in the United States. MMWR Recomm Rep. 2009 Jul 24;58(RR-7):1-26.

130.  De Bourdeaudhuij I, Van Cauwenberghe E, Spittaels H, et al. School-based interventions promoting both physical activity and healthy eating in Europe: a systematic review within the HOPE project. Obes Rev. 2011 Mar;12(3):205-16.

131.  Martin A, Booth JN, Laird Y, et al. Physical activity, diet and other behavioural interventions for improving cognition and school achievement in children and adolescents with obesity or overweight. Cochrane Database Syst Rev. 2018;(3):CD009728.

使用此内容应接受我们的免责声明